Source: ChemMedChem: chemistry enabling drug discovery. Unidade: IQSC
Subjects: ENZIMAS, COVID-19, QUÍMICA MÉDICA
ABNT
LAMEIRO, Rafael da Fonseca et al. Machine learning-guided repositioning of a SARS-CoV-2- targeting molecular series as cruzain inhibitors. ChemMedChem: chemistry enabling drug discovery, v. 21, p. e202500630, 2026Tradução . . Disponível em: https://doi.org/10.1002/cmdc.202500630. Acesso em: 11 fev. 2026.APA
Lameiro, R. da F., Silva, L. F. B. da, Cardoso, E. R., Ho, B. S., Martins, F. C. P., Melo, B. C. de, et al. (2026). Machine learning-guided repositioning of a SARS-CoV-2- targeting molecular series as cruzain inhibitors. ChemMedChem: chemistry enabling drug discovery, 21, e202500630. doi:10.1002/cmdc.202500630NLM
Lameiro R da F, Silva LFB da, Cardoso ER, Ho BS, Martins FCP, Melo BC de, Rosini F, Shamim A, Souza PM, Souza WF de, Montanari CA. Machine learning-guided repositioning of a SARS-CoV-2- targeting molecular series as cruzain inhibitors [Internet]. ChemMedChem: chemistry enabling drug discovery. 2026 ;21 e202500630.[citado 2026 fev. 11 ] Available from: https://doi.org/10.1002/cmdc.202500630Vancouver
Lameiro R da F, Silva LFB da, Cardoso ER, Ho BS, Martins FCP, Melo BC de, Rosini F, Shamim A, Souza PM, Souza WF de, Montanari CA. Machine learning-guided repositioning of a SARS-CoV-2- targeting molecular series as cruzain inhibitors [Internet]. ChemMedChem: chemistry enabling drug discovery. 2026 ;21 e202500630.[citado 2026 fev. 11 ] Available from: https://doi.org/10.1002/cmdc.202500630
